{
    "2018-08-26": [
        [
            {
                "time": "",
                "original_text": "贝达药业：积极配合推动抗癌药加快降价",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "抗癌药",
                        "降价"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "[买入评级] 贝达药业(300558)中报点评：埃克替尼以量补价效果初显 研发顺利推进",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "埃克替尼",
                        "以量补价",
                        "研发",
                        "买入评级"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}